OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Breast Cancer cDNA Array I

Be the first to review this product
SKU
BCRT501
TissueScan Breast Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
New! ER, PR and HER2 in Clinical Info.
  $2,500.00
In Stock*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Breast Cancer cDNA Array I
Clinical Info
Diagnosis Category Breast Cancer
Tissue Breast
Shipping Ambient
Description TissueScan Breast Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues
New! ER, PR and HER2 in Clinical Info.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer
Shehwana, Keskus, Ozdemir et al
Cell Oncol (Dordr) (2021)
Cited by 15
AI Summary: OriGene’s breast cancer tissue cDNA panel (BCRT501) was used to validate CHRNA5 expression across patient samples, contributing to the study’s assessment of its prognostic significance in breast cancer.
Snippet: Cholinergic signals can be important modulators of cellular signaling in cancer. We recently have shown that knockdown of nicotinic acetylcholine receptor.;A breast cancer tissue cDNA panel (BCRT501) was purchased from OriGene (Rockville, USA) and diluted in a ratio of 1:20 using ddH2O before use
Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases
Bu, Lu, Liu et al
Int J Cancer (2008) 123 (5), 1034-42 DOI: 10.1002/ijc.23625
Cited by 126
AI Summary: OriGene’s Human Dkk1 shRNA plasmid (OriGene, Cat# TL313293) was used in this study to silence Dkk1 expression in breast cancer cells, enabling the authors to demonstrate the specific role of Dkk1 in inhibiting osteoblast differentiation and osteoprotegerin expression.
FigureFigure
Showing 1-2 of 2 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products